Illumina, INC. SV-450-1003 prod care NSQ 500 comprehensive plan_base period
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800039P
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $114,349
Award facts
- Opportunity
-
- N02RC8250861 Solicitation number
- Renewal of Service Contract for Maintenance Agreement for NextSeq 500, Serial number: SV-450-1003. Award Notice · Posted Nov 17, 2017
- Contract value 78% obligated
-
- $114,348.99 Current, with exercised options
- $145,851.23 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20814, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $30,290 | |
| Exercise an Option | $29,125 | |
| Exercise an Option | $28,005 | |
| Original award | $26,928 |
About this award
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and consumables. The contract is for Illumina's NextSeq 500 Sequencing System Production Care comprehensive support plan, with a potential value of $145,851.23 and a completion date of January 31, 2023. Illumina has previously received awards from federal agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems, reagents, and services to support genomic research and diagnostics. This award does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN261201800039P?
HHSN261201800039P was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on February 1, 2018.
How much is contract HHSN261201800039P worth?
The government has obligated $114,349 on HHSN261201800039P. Its potential value, with all options, is $145,851.
Was contract HHSN261201800039P competed?
The extent of competition for HHSN261201800039P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award